Glomerular filtration rate decline in autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms;Progresion de la poliquistosis renal autosomica dominante. Influencia de polimorfismos de genes de sintasa endotelial del óxido ní trico (ecNOS) y del sistema renina-angiotensina

Medicina

Volumn 64, Issue 2, 2004, Pages 139-142

  Azurmendi, Pablo ^a   Fraga, Adriana ^a   Muchnik, Carolina ^a   Dos Ramos Farias, Maria ^a   Galan, Felicita ^a   Guerra, Danisa ^a   O'Flaherty, Martin ^b   Arrizurieta, Elvira ^a   Martín, Rodolfo S ^a,b  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

ADPKD; AGTM235T; AT1A1166C; ecNOSGlu298Asp; GFR decline

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; RAS PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; NOS3 PROTEIN, MOUSE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PHENOTYPE; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANIMAL; CHRONIC KIDNEY FAILURE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MOUSE; PATHOLOGY; REGRESSION ANALYSIS;

ADULT; ANGIOTENSINOGEN; ANIMALS; DISEASE PROGRESSION; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MICE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHENOTYPE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM;

EID: 4444232170     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chapman AB, Johnson A, Gabow PA, et al. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091-6.
2. Bloem LJ, Manatunga AK, Tewskbury DA, et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-53.
3. Hopkins PN, Lifton RP, Hollenberg NK, et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14: 199-207.
4. Morgan T, Craven C, Nelson L, et al. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest 1997; 100: 1406-5.
5. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 1994; 91: 3612-5.
6. Kim HS, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92: 2735-9.
7. 1166C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000; 36: 411-6.
8. Persu A, Stoenoiu T, Messiaen T, et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genetics 2002; 11: 229-41.
9. Peters DJ, Breuning MH. Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 2001; 358: 1439-44.
10. Baboolal K, Ravine D, Daniels J, et al. Association of the angiotensin I converting enzyme deletion polymor-phism with early onset ESRF in PKD1 adult polycystic kidney disease. Kidney Internat 1997; 52: 607-13.
11. Perez-Oller L, Torra R, Badenas C, et al. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999; 34: 273-8.
12. van Dijk MA, Breuning MH, Peters DJ, et al. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal polycystic kidney disease. Nephrol Dial Transpl 2000; 15: 836-9.
13. Saggar-Malik AK, Afzal AR, Jeffery S, et al. Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 2000; 4: 299-303.
14. KonoshitaT, Miyagi K, Onoe T et al. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 2001; 37: 113-8.
15. Walker D, Consugar M, Slezak J, et al. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis 2003; 41: 90-4.
16. Hateboer N, van Dijk MA, Bogdanova N, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999; 353: 103.